Clinical Trial Update: Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients [Phase 1]

View source ↗

Summary

An exploratory Phase 1 trial of MT-1303 in adults with systemic lupus erythematosus has been completed. The study was sponsored by Tanabe Pharma Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED